Key Segments:
By Category
-
Treatment
-
Diagnostics
By Treatment Procedure
-
Extracorporeal Shock Wave Lithotripsy
-
Ureteroscopy
-
Percutaneous Nephrolithotomy
-
Laser Lithotripsy
-
Others
By Stone Type
-
Calcium
-
Uric Acid
-
Struvite
-
Cysteine
By End User
-
Hospitals
-
Specialty Clinics
-
Ambulatory Surgical Centers
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Boston Scientific Corporation, Olympus Corporation, Cook Medical LLC, Storz Medical AG, Medispec Ltd., and Dornier MedTech GmbH, among other medical device manufacturers.
Continued advancement of laser lithotripsy technology and continued expansion of ambulatory surgical center capacity represent the primary opportunities.
Growth is primarily driven by rising prevalence and recurrence of kidney stones, combined with continued adoption of minimally invasive treatment technology.
By Category, Treatment dominated the market with a 58.60% share in 2025, reflecting sustained demand for lithotripsy systems, scopes, and disposables.
North America dominated the market with a 38.60% share in 2025, supported by high kidney stone prevalence and broad insurance coverage.
